223 related articles for article (PubMed ID: 33313327)
1. Increased Frequencies of Switched Memory B Cells and Plasmablasts in Peripheral Blood from Patients with ANCA-Associated Vasculitis.
Elmér E; Smargianaki S; Pettersson Å; Skattum L; Ohlsson S; Hellmark T; Johansson ÅCM
J Immunol Res; 2020; 2020():8209737. PubMed ID: 33313327
[TBL] [Abstract][Full Text] [Related]
2. Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients.
van Dam LS; Oskam JM; Kamerling SWA; Arends EJ; Bredewold OW; Berkowska MA; van Dongen JJM; Rabelink TJ; van Kooten C; Teng YKO
Front Immunol; 2020; 11():566732. PubMed ID: 33384685
[TBL] [Abstract][Full Text] [Related]
3. Identification and phenotyping of circulating autoreactive proteinase 3-specific B cells in patients with PR3-ANCA associated vasculitis and healthy controls.
Cornec D; Berti A; Hummel A; Peikert T; Pers JO; Specks U
J Autoimmun; 2017 Nov; 84():122-131. PubMed ID: 28870527
[TBL] [Abstract][Full Text] [Related]
4. Effect of high mobility group box 1 on Toll-like receptor 9 in B cells in myeloperoxidase-ANCA-associated vasculitis.
Wang C; Deng H; Gong Y; You R; Chen M; Zhao MH
Autoimmunity; 2020 Feb; 53(1):28-34. PubMed ID: 31790283
[TBL] [Abstract][Full Text] [Related]
5. CD27
von Borstel A; Land J; Abdulahad WH; Rutgers A; Stegeman CA; Diepstra A; Heeringa P; Sanders JS
Front Immunol; 2019; 10():2221. PubMed ID: 31608054
[No Abstract] [Full Text] [Related]
6. Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission.
Tadema H; Abdulahad WH; Lepse N; Stegeman CA; Kallenberg CG; Heeringa P
Rheumatology (Oxford); 2011 Apr; 50(4):689-96. PubMed ID: 21149241
[TBL] [Abstract][Full Text] [Related]
7. A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis.
Arnold J; Vital EM; Dass S; Aslam A; Rawstron AC; Savic S; Emery P; Md Yusof MY
Front Immunol; 2021; 12():803175. PubMed ID: 35095887
[TBL] [Abstract][Full Text] [Related]
8. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
[TBL] [Abstract][Full Text] [Related]
9. Disease Activity and Tendency to Relapse in ANCA-Associated Vasculitis Are Reflected in Neutrophil and Intermediate Monocyte Frequencies.
Smargianaki S; Elmér E; Lilliebladh S; Ohlsson S; Pettersson Å; Hellmark T; Johansson ÅC
J Immunol Res; 2024; 2024():6648265. PubMed ID: 38213873
[TBL] [Abstract][Full Text] [Related]
10. Alterations in circulating lymphoid cell populations in systemic small vessel vasculitis are non-specific manifestations of renal injury.
Fazekas B; Moreno-Olivera A; Kelly Y; O'Hara P; Murray S; Kennedy A; Conlon N; Scott J; Melo AM; Hickey FB; Dooley D; O'Brien EC; Moran S; Doherty DG; Little MA
Clin Exp Immunol; 2018 Feb; 191(2):180-188. PubMed ID: 28960271
[TBL] [Abstract][Full Text] [Related]
11. Significant association between clinical characteristics and immuno-phenotypes in patients with ANCA-associated vasculitis.
Matsumoto K; Suzuki K; Yoshimoto K; Seki N; Tsujimoto H; Chiba K; Takeuchi T
Rheumatology (Oxford); 2020 Mar; 59(3):545-553. PubMed ID: 31377799
[TBL] [Abstract][Full Text] [Related]
12. Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions.
Md Yusof MY; Vital EM; Das S; Dass S; Arumugakani G; Savic S; Rawstron AC; Emery P
Ann Rheum Dis; 2015 Sep; 74(9):1734-8. PubMed ID: 25854586
[TBL] [Abstract][Full Text] [Related]
13. Natural Killer Cells in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - A Review of the Literature.
Fuchs S; Scheffschick A; Gunnarsson I; Brauner H
Front Immunol; 2021; 12():796640. PubMed ID: 35116030
[TBL] [Abstract][Full Text] [Related]
14. Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.
Simon D; Balogh P; Erdő-Bonyár S; Böröcz K; Minier T; Czirják L; Berki T
Front Immunol; 2021; 12():686483. PubMed ID: 34276673
[TBL] [Abstract][Full Text] [Related]
15. Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).
Charles P; Terrier B; Perrodeau É; Cohen P; Faguer S; Huart A; Hamidou M; Agard C; Bonnotte B; Samson M; Karras A; Jourde-Chiche N; Lifermann F; Gobert P; Hanrotel-Saliou C; Godmer P; Martin-Silva N; Pugnet G; Matignon M; Aumaitre O; Viallard JF; Maurier F; Meaux-Ruault N; Rivière S; Sibilia J; Puéchal X; Ravaud P; Mouthon L; Guillevin L;
Ann Rheum Dis; 2018 Aug; 77(8):1143-1149. PubMed ID: 29695500
[TBL] [Abstract][Full Text] [Related]
16. Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.
Lenert A; Lenert P
Drug Des Devel Ther; 2015; 9():333-47. PubMed ID: 25609919
[TBL] [Abstract][Full Text] [Related]
17. The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells.
Werner K; Dolff S; Dai Y; Ma X; Brinkhoff A; Korth J; Gäckler A; Rohn H; Sun M; Cohen Tervaert JW; van Paassen P; Kribben A; Witzke O; Wilde B
Front Immunol; 2019; 10():2843. PubMed ID: 31921121
[No Abstract] [Full Text] [Related]
18. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission.
Lepse N; Abdulahad WH; Rutgers A; Kallenberg CG; Stegeman CA; Heeringa P
Rheumatology (Oxford); 2014 Sep; 53(9):1683-92. PubMed ID: 24729403
[TBL] [Abstract][Full Text] [Related]
19. Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Berti A; Hillion S; Konig MF; Moura MC; Hummel AM; Carmona E; Peikert T; Fervenza FC; Kallenberg CGM; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; Brunetta P; St Clair EW; Harris KM; Stone JH; Grandi G; Pers JO; Specks U; Cornec D
Arthritis Rheumatol; 2023 May; 75(5):736-747. PubMed ID: 36281741
[TBL] [Abstract][Full Text] [Related]
20. Is serum HMGB1 a biomarker in ANCA-associated vasculitis?
de Souza A; Westra J; Bijzet J; Limburg PC; Stegeman CA; Bijl M; Kallenberg CG
Arthritis Res Ther; 2013; 15(5):R104. PubMed ID: 24007972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
